SCAVONE, Cristina
 Distribuzione geografica
Continente #
EU - Europa 5.402
NA - Nord America 2.348
AS - Asia 2.339
SA - Sud America 466
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 10.590
Nazione #
RU - Federazione Russa 3.813
US - Stati Uniti d'America 2.292
SG - Singapore 817
IE - Irlanda 526
CN - Cina 453
BR - Brasile 395
IT - Italia 370
VN - Vietnam 369
HK - Hong Kong 324
DE - Germania 181
GB - Regno Unito 179
KR - Corea 99
UA - Ucraina 85
IN - India 68
JP - Giappone 64
GR - Grecia 48
FI - Finlandia 34
TR - Turchia 30
BD - Bangladesh 29
CA - Canada 28
FR - Francia 28
AR - Argentina 26
SE - Svezia 18
EC - Ecuador 17
ID - Indonesia 16
MX - Messico 15
NL - Olanda 15
PL - Polonia 14
ES - Italia 13
AT - Austria 12
CZ - Repubblica Ceca 12
BE - Belgio 11
IQ - Iraq 11
ZA - Sudafrica 11
CO - Colombia 10
UZ - Uzbekistan 9
AL - Albania 7
PK - Pakistan 7
SA - Arabia Saudita 7
SC - Seychelles 7
VE - Venezuela 7
CH - Svizzera 6
CL - Cile 5
IR - Iran 5
HU - Ungheria 4
KG - Kirghizistan 4
LT - Lituania 4
NP - Nepal 4
PY - Paraguay 4
RS - Serbia 4
BG - Bulgaria 3
DK - Danimarca 3
EG - Egitto 3
JM - Giamaica 3
MA - Marocco 3
PR - Porto Rico 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 10.590
Città #
Moscow 1.370
Dublin 523
San Jose 431
Singapore 403
Hong Kong 320
Santa Clara 317
Chandler 195
Jacksonville 158
Ashburn 143
Ho Chi Minh City 101
Seoul 97
Beijing 75
Hanoi 71
Bremen 70
Princeton 69
Roxbury 69
Hefei 63
Dong Ket 60
Medford 46
São Paulo 41
Ann Arbor 38
Aversa 37
The Dalles 37
Caserta 34
Los Angeles 33
Naples 32
Munich 30
Dallas 29
Bengaluru 28
New York 27
Memphis 24
Napoli 24
Wilmington 24
Cambridge 23
Da Nang 19
Orem 18
Woodbridge 18
Des Moines 17
Rio de Janeiro 16
Nuremberg 14
Toronto 13
Milan 12
Nanjing 12
Salerno 12
Brno 11
Brussels 11
Falkenstein 11
Hanover 11
Helsinki 11
Chennai 10
London 10
Phủ Lý 10
Mexico City 9
Mountain View 9
Amsterdam 8
Atlanta 8
Biên Hòa 8
Council Bluffs 8
Haiphong 8
Hải Dương 8
Jinan 8
Johannesburg 8
Rome 8
Tashkent 8
Brasília 7
Changsha 7
Columbus 7
Curitiba 7
Guangzhou 7
Jakarta 7
Norwalk 7
San Francisco 7
Turku 7
Warsaw 7
Boardman 6
Düsseldorf 6
Frankfurt am Main 6
Kunming 6
Manchester 6
Piracicaba 6
Redwood City 6
Auburn Hills 5
Baghdad 5
Belo Horizonte 5
Chicago 5
City of London 5
Dearborn 5
Guayaquil 5
Istanbul 5
New Delhi 5
Newark 5
Quito 5
Tirana 5
Vienna 5
Wroclaw 5
Asunción 4
Bogotá 4
Bologna 4
Brooklyn 4
Buffalo 4
Totale 5.578
Nome #
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 196
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 187
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 181
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation? 180
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 179
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 176
Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population 172
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 167
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension 166
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 158
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 158
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 157
Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation 156
Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve 151
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 148
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction 146
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 144
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 144
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System 143
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? (Heart Failure Reviews, (2020), 10.1007/s10741-020-09961-9) 142
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 141
Current pharmacological treatments for COVID-19: What's next? 138
Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System 136
Disclosing negative trial results – procedure 135
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database 134
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 133
Mid-term follow-up after COVID-19 vaccination in adults with CHD: a prospective study 129
Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 127
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System 125
The Potential Benefits of a Novel Food Supplement Based on Cannabis Sativa, Boswellia, and Fish Oil for Pain and Inflammation in Physical Activity: Unraveling the Role of Orexin-A Modulation 124
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 124
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 123
Disclosure of negative trial results. A call for action 121
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data 118
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 118
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination 117
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 116
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review 116
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 116
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study 115
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 113
Gender differences in outpatient pediatric drug utilization: A cohort study from southern Italy 113
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 113
Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: A network meta-analysis and regression 111
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 111
Influenza vaccine hesitancy in patients with multiple sclerosis: A monocentric observational study 111
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report 111
The Use of Botulinum Toxin Type A and the Occurrence of Anaphylaxis: A Descriptive Analysis of Data from the European Spontaneous Reporting System 109
Parental vaccine hesitancy: Recent evidences support the need to implement targeted communication strategies 108
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 108
Therapeutic strategies to fight COVID-19: Which is the status artis? 108
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 106
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 106
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 106
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 105
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 105
Renin-angiotensin system and coronavirus disease 2019: A narrative review 105
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series 103
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system 103
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 103
Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice 103
Two Unexpected Cases of Rosacea during Fingolimod Therapy 103
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 103
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System 102
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF) 99
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 99
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 98
The European clinical trials regulation (No 536/2014): changes and challenges 96
Tisagenlecleucel in children and young adults: Reverse translational research by using real‐world safety data 96
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 96
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 95
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database 94
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 94
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis 94
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 91
Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data 89
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 89
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? 87
Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust 86
Italian immunization goals: A political or scientific heated debate? 86
Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study 86
Hyponatremia following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports from the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review 86
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 83
Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: A retrospective observational study in Southern Italy 83
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. 82
Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings: a meta-analysis and meta-regression 79
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy 78
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment 78
The safety profile of general and local anaesthetic agents: Data collected during 20 years of spontaneous reporting activities in the campania region (southern italy) 78
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines 76
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study 75
Flu vaccination in multiple sclerosis patients: a monocentric prospective vaccine-vigilance study 39
null 18
Facts and figures of the compassionate use of onco-hematological drugs from 2016 to 2021: Results from the multicentric observational study Compass-O 13
Hepatobiliary disorders and Direct-Acting Antiviral (DAA) therapies: real-world evidence and insights from the EudraVigilance database 8
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database 7
Totale 10.784
Categoria #
all - tutte 35.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 0 0 69
2021/2022401 3 7 11 5 126 13 19 14 21 18 23 141
2022/2023981 134 36 18 60 107 59 6 47 467 4 25 18
2023/2024407 24 3 15 13 135 13 7 72 12 3 34 76
2024/20251.413 6 21 20 32 204 178 238 116 223 127 131 117
2025/20266.630 285 305 315 358 562 3.524 254 372 239 236 121 59
Totale 10.784